MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Autosomal recessive spastic ataxia of Charlevoix–Saguenay: Case report with 3 family members affected.

    H. Pacheco Mendoza, L. Nuñez Orozco, P. Briseño López, A. Negrete Gómez, J. Delgado Uriarte (Mexico, Mexico)

    Objective: Report a case of ARSACS in a patient with 2 siblings also affected Background: Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is a rare…
  • 2024 International Congress

    Assessment of Cerebellar Ataxia Severity in Patients with Posterior Cranial Fossa Tumors Using CASAS Scale

    D. Khodjimetov (Tashkent, Uzbekistan)

    Objective: To develop a scale for assessing the severity of cerebellar ataxia in patients with PCFT Background: Cerebellar ataxia (CA) is prevalent in patients with…
  • 2024 International Congress

    Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report

    C. Bedeschi, P. Junior (Barueri, Brazil)

    Objective: The aim of this research was to develop and verify the effects of a Non-Invasive Neuromodulation protocol associated with Neurofunctional Physiotherapy on motor functions,…
  • 2024 International Congress

    Choreiform Movements Secondary to Sarcoidosis Without Central Nervous System Granulomatosis

    O. Carranza-Renteria, T. Hammond (Boca Raton, USA)

    Objective: To share our experience managing a patient who presented with choreiform movements found to be secondary to sarcoidosis without CNS Granulomatosis. Background: Sarcoidosis is…
  • 2024 International Congress

    Diabetic striatopathy with stroke – like symptoms: A case report

    A. Alonso, C. Araque, B. Marquez (Bogotá, Colombia)

    Objective: To describe a rare case of diabetic striatopathy in a woman with type 2 diabetes mellitus presenting with unilateral hemichorea, dysarthria and left hemiparesis…
  • 2024 International Congress

    Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

    A. Ellenbogen, R. Hauser, A. Patel, P. Mcallister, D. Vitarella, T. Gross, R. Kazerooni, C. Gallagher, D. Hollander (Farmington Hills, USA)

    Objective: To assess the residual therapeutic efficacy of prior botulinum toxin (BoNT) injection at the patient-desired retreatment interval in cervical dystonia (CD). Background: BoNT injections…
  • 2024 International Congress

    Clinical Outcomes and Local Field Potential Characteristics in Bilateral GPi DBS in 2 cases of X-Linked Dystonia Parkinsonism

    E. Donlon, C. O'Keefe, G. Mullane, F. Ruggieri, M. Alexander, C. Moran, T. Lynch, C. Fearon, E. Pereira, R. Walsh (Dublin, Ireland)

    Objective: We describe clinical outcomes and local field potential characteristics in 2 cases of fulminant onset XDP who went on to have bilateral GPi DBS…
  • 2024 International Congress

    Structural and Functional Brain Alterations in Laryngeal Dystonia: A Coordinate-Based Activation Likelihood Estimation Meta-Analysis

    N. Kshatriya, G. Battistella, K. Simonyan (Boston, USA)

    Objective: Efforts to understand laryngeal dystonia (LD) pathophysiology using neuroimaging techniques have demonstrated altered brain structure and function in patients compared to healthy controls1-5. However,…
  • 2024 International Congress

    A Survey of Immunological Mechanisms in Cervical Dystonia

    L. Scorr, G. Kilic-Berkmen, J. Mckay, D. Sutcliffe, A. Mckeon, H. Jinnah (Atlanta, USA)

    Objective: The overall goal was to delineate which aspects of the immune system may be most relevant to the biology of CD. Background: Although several…
  • 2024 International Congress

    Non-motor symptoms in people with Huntington’s disease: use and validation of the MDS Non-Motor Scale (MDS-NMS)

    JM. Valera-Bermejo, N. Martins, O. Makos, J. Badenoch, M. Hartmann, A. Rangel-Cristales, A. Rizos, K. Ray Chaudhuri, D. van Wamelen (London, United Kingdom)

    Objective: The primary objective of this project is to validate and personalise the existing MDS-NMS scale, originally developed for Parkinson’s disease, for use in people…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley